Product News and Recalls

Beyaz on list of libido-inhibiting drugs

AdverseEvents, Inc., has listed oral contraceptive Beyaz as one of the drugs most related to loss of libido.

Beyaz shares the list with drugs for prostate problems, anti-depressants, and even the hair loss medication Propecia.

AdverseEvents, Inc. – which collates information from the federal Food and Drug Administration Adverse Events Reporting System database – compiled a list of FDA approved medications most associated with causing brain-related side effects in recognition of Brain Awareness Week (March 12-18).

Other reported side effects from Beyaz ...

continue reading...

Yaz maker Bayer criticized over “price gouging”

International health advocates are criticizing Bayer after the German pharmaceutical giant announced it may contest a decision that could make life-saving medication available to cancer patients in the developing world.

In a landmark case, the Indian Patent Office issued a compulsory license in India to a generic drug manufacturer, effectively ending Bayer’s monopoly on a drug used to treat kidney and liver cancer.

According to international humanitarian organization Doctors Without Borders, competition from the generic version will bring the price of the ...

continue reading...

Writer attributes blood clot death to Yaz

In an issue of “Salon,” blogger Jonathan Manor writes about the death of an acquaintance from a blood clot in her lung, which he attributes to her use of the contraceptive Yaz.

In the piece called “Yaz Birth Control Killed the Sister I Never Knew,” Manor describes being in the hospital when the woman – the sibling of his brother’s girlfriend – died.

“When we got to the hospital it was what it was; excruciating pain, prayer, emotions running rampant,” Manor writes.

A ...

continue reading...

Women’s health advocates criticize FDA panel

A group of women’s health advocates recently sent a letter to U.S. Food and Drug Administration Commissioner Margaret Hamburg, M.D.  The letter expressed the their concern about an FDA committee that voted to keep birth control pills containing the compound drospirenone — including Yaz, Yasmin, Ocella and Beyaz – on the market.

Signing the letter were the executive directors of the Jacobs Institute of Women’s Health, the National Research Center for Women ...

continue reading...

Brilliant Blue G recalled over contamination concerns

The U.S. Food and Drug administration sent out a notice to physicians recently that Brilliant Blue G – a food dye that’s also been found to have medical applications — from Franck’s Lab is being recalled because of concerns over possible fungal contamination.

According to the notice, the FDA received reports that patients being treated with Brilliant Blue G have suffered fungal eye infections.

The dye has been used by eye surgeons to help them better differentiate various parts of the eye.

See ...

continue reading...

Departing Johnson & Johnson CEO Weldon getting $143.5 million

Departing Johnson & Johnson Chief Executive Officer William C. Weldon, who is leaving after a spate of disastrous recalls, will get $143.5 million in retirement pay, according to Bloomberg.

Bloomberg reports that Weldon, 63, will remain chairman. He amassed $95.1 million in deferred and long-term compensation during his 40 years with the company, and his pension has a present value of $48.4 million.

The report mentions that the company struggled with recalls of artificial hip implants and over-the-counter drugs, and safety concerns ...

continue reading...
Page 297 of 317 «...270280290295296297298299...»